230. Alveolar hypoventilation syndrome Clinical trials / Disease details
Clinical trials : 6 / Drugs : 7 - (DrugBank : 4) / Drug target genes : 16 - Drug target pathways : 26
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2005-005950-33-SE (EUCTR) | 07/06/2006 | 10/04/2006 | Studie av Domperidon och barn med kongenitalt centralt hypoventilationssyndrom. - DOMPCCHSSWE1 | Studie av Domperidon och barn med kongenitalt centralt hypoventilationssyndrom. - DOMPCCHSSWE1 | Congenital central hypoventilation syndrome, CCHS or Ondine's curse. | Trade Name: Motilium Product Name: Motilium INN or Proposed INN: Domperidone | Karolinska Universitetssjukhuset | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Sweden |